会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • POST-TREATMENT BREAST CANCER PROGNOSIS
    • 治疗后乳腺癌预后
    • US20130281502A1
    • 2013-10-24
    • US13914617
    • 2013-06-10
    • Dennis SgroiMark G. ErlanderYi ZhangCatherine A. Schnabel
    • Dennis SgroiMark G. ErlanderYi ZhangCatherine A. Schnabel
    • C12Q1/68
    • C12Q1/6886C12Q2600/106C12Q2600/118C12Q2600/158
    • The disclosure includes the identification and use of gene expression profiles, or patterns, with clinical relevance to extended treatment and cancer-free survival in a patient. In particular, the disclosure includes the identities of genes that are expressed in correlation with benefit in a switch in endocrine therapy used to treat a patient. The levels of gene expression are disclosed as a molecular index for predicting clinical outcome, and so prognosis, for the patient. The disclosure further includes methods for predicting cancer recurrence, and/or predicting occurrence of metastatic cancer, after initial treatment with an anti-estrogen agent. The disclosure further includes methods for determining or selecting the treatment of a subject based upon the likelihood of life expectancy, cancer recurrence, and/or cancer metastasis.
    • 该公开内容包括鉴定和使用基因表达谱或模式,其与患者中延长的治疗和无癌生存具有临床相关性。 具体地,本公开包括与用于治疗患者的内分泌治疗的转换中的益处相关表达的基因的身份。 公开了基因表达水平作为预测临床结果的分子指标,并为患者预后。 本发明还包括在用抗雌激素剂初次治疗后预测癌症复发和/或预测转移性癌症的发生的方法。 本公开还包括基于预期寿命,癌症复发和/或癌症转移的可能性来确定或选择受试者的治疗的方法。
    • 18. 发明授权
    • Method for simultaneous sequence-specific identification and display of mRNA's
    • 同时序列特异性鉴定和mRNA显示的方法
    • US06596484B1
    • 2003-07-22
    • US09650229
    • 2000-08-29
    • J. Gregor SutcliffeMark G. ErlanderKarl W. Hasel
    • J. Gregor SutcliffeMark G. ErlanderKarl W. Hasel
    • C12Q168
    • C12Q1/6853C12N15/1096C12Q1/6809C12Q2535/138C12Q2525/185C12Q2525/173C12Q2525/131
    • An improved method for the simultaneous sequence-specific identification of mRNAs in a mRNA population allows the visualization of nearly every mRNA expressed by a tissue as a distinct band on a gel whose intensity corresponds roughly to the concentration of the mRNA. In general, the method comprises the formation of cDNA using anchor primers to fix a 3′-endpoint, producing cloned inserts from the cDNA in a vector containing a bacteriophage-specific promoter for subsequent RNA synthesis, generating linearized fragments of the cloned inserts, preparing cRNA, transcribing cDNA from the cRNA using a set of primers, and performing PCR using a 3′-primer whose sequence is derived from the vector and a set of 5′-primers that is derived from the primers used for transcription of cDNA from cRNA. The method can identify changes in expression of mRNA associated with the administration of drugs or with physiological or pathological conditions.
    • 用于mRNA同种序列特异性鉴定mRNA群体的改进方法允许将组织表达的几乎每个mRNA作为凝胶上的不同条带进行可视化,其强度大致对应于mRNA的浓度。 通常,该方法包括使用锚定引物形成cDNA以固定3'端点,在含有噬菌体特异性启动子的载体中从cDNA产生克隆的插入片段用于随后的RNA合成,产生克隆插入物的线性化片段,制备 cRNA,使用一组引物从cRNA转录cDNA,并使用序列衍生自载体的3'-引物进行PCR,以及从用于从cRNA转录cDNA的引物衍生的一组5'-引物 。 该方法可以鉴定与给药药物或生理或病理状况相关的mRNA的表达变化。